Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome

@article{Robain2000FlecainideassociatedPW,
  title={Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome},
  author={Anne Robain and H Perchet and Claire Fchrman},
  journal={Acta Cardiologica},
  year={2000},
  volume={55},
  pages={45 - 47}
}
Antiarrhythmic agents can cause pneumonitis. Flecainide is a rare cause of hypersensitivity pneumonitis, and few cases have been reported. We describe a case of interstitial hypoxaemiant pneumonitis probably related to flecainide in a patient with the LEOPARD syndrome, a rare congenital disorder. 
5 Citations

Diffuse Infiltrative Lung Disease Associated with Flecainide

Two patients who developed subacute diffuse infiltrative lung disease while receiving flecainide for supraventricular arrhythmia were presented and increased numbers of lymphocytes and eosinophils, and a low CD4/CD8 ratio were revealed.

Flecainide-induced pneumonitis: a case report

Clinical and radiological improvement was noted after corticosteroid therapy, but the patient died from septic complications, and flecainide-induced lung injury has rarely been reported in the literature and remains a diagnosis of exclusion.

Anaesthetic implications of LEOPARD syndrome

The authors present a 4‐year old boy who presented for anaesthetic care for repair of a ventricular septal defect and pulmonary valvotomy for congenital pulmonary stenosis and the potential perioperative implications of LEOPARD syndrome are discussed.

Drug-induced and iatrogenic respiratory disease

Pneumonitis induced by non-cytotoxic agents Amiodarone pulmonary toxicity Eosinophilic pneumoniainduced by drugs Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy.

References

SHOWING 1-10 OF 10 REFERENCES

Tocainide-associated interstitial pneumonitis.

It appears that in patients with life-threatening ventricular arrhythmias, tocainide is a safe agent with a favourable risk-benefit ratio.

Irreversible interstitial pneumonitis associated with tocainide therapy.

32. Graettinger JS, Muenster JJ, Selvertone LA, et al: A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. J Clin Invest

Tocainide: interstitial pneumonitis.

  • S. Ahmad
  • Medicine
    Journal of the American College of Cardiology
  • 1990

Lazarus 'vi . L1 C lrrevcr~1hlc 1111er~ti tial pncumonit1s associa1ed with tocainide Lherap)

  • We.it J .\led
  • 1988

associated , 1th cutaneous lenllg111os1s. allom:d d1agno-;1.., of the LEOP.\RD s)-ndrome. S1.\ month-. later the patient reports

  • PO:! T 1 mm Hg. PCO 2 36 mm Hg

Mulllple lentigine, syndrome. Case repon ant.I re\1c,~ of literature

    Tocm n1dc: 101crsulial pneumomus

    • J Am ( ol/ Ccmliol